Viagen Biotech
Viagen Biotech is a privately held Los Angeles-based supplier of DNA extraction technologies and consumable products for life science research customers, founded in 2001 and operating with a micro-scale team.
- Company typePrivate
- Founded2001
- HeadquartersLos Angeles, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Viagen Biotech does
Viagen Biotech is a privately held provider of DNA extraction technologies and products for the life science research market. The company is headquartered in Los Angeles, California, and was founded in 2001, giving it more than two decades of operating history in a specialized consumables category used by academic, government, and commercial laboratories.
The firm's core offering centers on DNA extraction products used by researchers, though the specific product portfolio, underlying technology platforms, proprietary chemistry, and catalog breadth were not disclosed in the available source material. The corporate website (viagenbiotech.com) did not render substantive content during data collection, displaying only a loader/verification page, so product-level technical detail is not available for this assessment. No patents, certifications, regulatory clearances, or AI/ML capabilities were identified.
Business model details — including pricing structure, distribution channels, revenue mechanics, and customer segmentation — are not documented in the source data. The firm operates with a very small headcount of 1-10 employees, has no disclosed funding history, no management team bios, no named customers, and no public revenue figures. As a result, while the company clearly functions as a niche supplier in the life science research tools value chain, the operational, commercial, and financial characteristics of the business cannot be substantiated beyond its basic firmographic profile.
Viagen Biotech firmographics
Firmographics- Name
- Viagen Biotech
- Website
- https://viagenbiotech.com
- Company type
- Private
- Founded year
- 2001
- Headcount range
- 1–10 employees
- Short description
- Viagen Biotech is a privately held Los Angeles-based supplier of DNA extraction technologies and consumable products for life science research customers, founded in 2001 and operating with a micro-scale team.
- Ownership category
- akta.pro rank
Viagen Biotech industry classification
Industry- Product category
- Life Science Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
- akta.pro secondary industry
- Transcriptomics & Gene Expression Profiling Services (HLAGANAE)
Keywords
Where Viagen Biotech is headquartered
LocationHeadquarters
- HQ city
- Los Angeles
- HQ country
- United States
- HQ region
- North America
Markets served
Viagen Biotech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Technology or R&D
Viagen Biotech product offering
Product offeringCore offering
Viagen Biotech provides DNA extraction technologies and products used in life science research. The company's offering supports genomic and molecular biology workflows by supplying the consumables and reagents researchers need to isolate and purify DNA from biological samples.
Differentiator
Problem solved
Functional benefit
Products and services
- DNA Extraction Products
Companies that use Viagen Biotech
Customer profileIdeal customer profiles1 record
Viagen Biotech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Viagen Biotech partnerships and signals
Strategic signalExpansion highlights2 records
Viagen Biotech competitors and assessment
Company assessmentDirect peers
- Qiagen: Global leader in DNA/RNA extraction kits and sample preparation consumables; directly competes with Viagen in the same product category across research and molecular diagnostics customers.
- New England Biolabs: Developer of reagents for life science research including DNA purification and sample prep tools; a closely aligned direct peer in molecular biology consumables.
- Macherey-Nagel: German supplier of DNA/RNA extraction kits (NucleoSpin family) widely used in academic labs; direct competitor in the same extraction reagent category.
- Promega Corporation: Manufacturer of molecular biology reagents including DNA extraction and purification products; comparable in serving academic and clinical research customers with consumables.
- Zymo Research: Specialty provider of DNA/RNA extraction kits, particularly for microbiome and epigenetics applications; a focused direct competitor serving the same life science research buyer.
- Omega Bio-tek: Specialty manufacturer of DNA/RNA extraction kits, particularly strong in soil, tissue, and environmental sample types; a focused niche peer comparable in size and product scope.
Broad incumbents
- Thermo Fisher Scientific: Dominant life science tools incumbent offering DNA extraction reagents under the Invitrogen brand; competes broadly across the same workflows but as part of a much wider portfolio.
- Bio-Rad Laboratories: Diversified life science research and clinical diagnostics company whose reagent portfolio includes DNA extraction and purification products; overlaps in customer base and product category.
- Meridian Bioscience: Diagnostics and life science reagent manufacturer with molecular biology products including sample preparation; broader incumbent with overlapping molecular workflows.
Emerging players
- LGC Biosearch Technologies: Genomics-focused reagent provider covering nucleic acid extraction and related sample prep; an emerging/specialty peer with overlapping molecular biology consumable offerings.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat1 record
Key risks5 records
Key highlights3 records
Customer concentration
Viagen Biotech social profiles
Digital presenceViagen Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Viagen Biotech leadership team
Management profileNumber of profiles
Viagen Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Viagen Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Viagen Biotech
What does Viagen Biotech do?
Viagen Biotech provides DNA extraction technologies and products used in life science research. The company's offering supports genomic and molecular biology workflows by supplying the consumables and reagents researchers need to isolate and purify DNA from biological samples.
When was Viagen Biotech founded?
Viagen Biotech was founded in 2001. It employs 1 to 10 people.
Where is Viagen Biotech based?
Viagen Biotech is headquartered in Los Angeles, United States, in the North America region.
Who are Viagen Biotech's main competitors?
Direct peers on record are Qiagen, New England Biolabs, Macherey-Nagel, Promega Corporation, Zymo Research and Omega Bio-tek. Broad incumbents are Thermo Fisher Scientific, Bio-Rad Laboratories and Meridian Bioscience. LGC Biosearch Technologies is listed as an emerging player.
Does Viagen Biotech have an API?
No public API is recorded for Viagen Biotech.
What industry is Viagen Biotech in?
Viagen Biotech's product category is Life Science Reagents. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAGANAE, Transcriptomics & Gene Expression Profiling Services. Its NAICS code is 325413 and its SIC code is 3826.